• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌组织学类型对基于全血细胞计数得出的炎症标志物的影响——当前认知与未来展望

The Impact of the Histologic Types of Lung Cancer on CBC-Derived Inflammatory Markers-Current Knowledge and Future Perspectives.

作者信息

Mariean Claudia Raluca, Tiucă Oana Mirela, Mariean Alexandru, Szekely Tiberiu-Bogdan, Niculescu Raluca, Sabau Adrian Horatiu, Al-Akel Cristina Flavia, Cotoi Ovidiu Simion

机构信息

Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania.

Pathophysiology Department, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania.

出版信息

J Clin Med. 2025 Apr 28;14(9):3038. doi: 10.3390/jcm14093038.

DOI:10.3390/jcm14093038
PMID:40364072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12072615/
Abstract

: The analysis of the complete blood count (CBC)-derived inflammatory indexes across different histological subtypes of lung cancer supports the early detection of tumor-induced inflammation and has a good predictive value for severity in cancer patients. The main objective of this article was to assess the variations in CBC-derived inflammatory markers across different histologic subtypes of lung cancer, with the final goal of identifying specific predictors of severity for each histologic subtype of lung cancer. : We conducted a retrospective descriptive study that included 202 patients diagnosed with lung carcinoma at the Clinical County Hospital Mureș. The analyzed parameters were as follows: the histological type, the stage of the tumor, patients' general data, and associated comorbidities. In addition, nine CBC-derived inflammatory indexes, like the neutrophil-to-lymphocyte ratio (NLR), derived neutrophil-to-lymphocyte ratio (d-NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), eosinophil-to-neutrophil ratio (ENR), eosinophil-to-monocyte ratio (EMR), systemic inflammatory index (SII), systemic inflammatory response index (SIRI), and aggregate index of systemic inflammation (AISI), were analyzed as predictors of severity and correlated with histologic findings. : The predictors of severity differed across the histologic subtypes. SIRI, d-NLR, and age were predictors of severity in adenocarcinoma patients, while the d-NLR, ENR, leukocyte, and neutrophil count predicted severity in squamous cell carcinoma. For SCLC patients, AISI, SIRI, SII, d-NLR, EMR, ENR, MLR, leukocyte count, lymphocyte count, neutrophil count, platelets count, COPD, smoking, and male gender were predictors for severity. Understanding the complexity and variations in the inflammatory response across different histologic types of lung cancer can personalize treatment regimens and target specific abnormal cellular lines, thus improving the outcome of this highly deadly condition.

摘要

对不同组织学亚型肺癌患者全血细胞计数(CBC)衍生的炎症指标进行分析,有助于早期发现肿瘤诱导的炎症,对癌症患者的病情严重程度具有良好的预测价值。本文的主要目的是评估不同组织学亚型肺癌患者CBC衍生炎症标志物的变化,最终目标是确定每种组织学亚型肺癌严重程度的特定预测指标。我们进行了一项回顾性描述性研究,纳入了202例在穆列什县临床医院被诊断为肺癌的患者。分析的参数如下:组织学类型、肿瘤分期、患者的一般资料以及相关合并症。此外,还分析了9个CBC衍生的炎症指标,如中性粒细胞与淋巴细胞比值(NLR)、衍生中性粒细胞与淋巴细胞比值(d-NLR)、单核细胞与淋巴细胞比值(MLR)、血小板与淋巴细胞比值(PLR)、嗜酸性粒细胞与中性粒细胞比值(ENR)、嗜酸性粒细胞与单核细胞比值(EMR)、全身炎症指数(SII)、全身炎症反应指数(SIRI)和全身炎症聚集指数(AISI),作为病情严重程度的预测指标,并与组织学结果进行关联分析。不同组织学亚型的病情严重程度预测指标有所不同。SIRI、d-NLR和年龄是腺癌患者病情严重程度的预测指标,而d-NLR、ENR、白细胞计数和中性粒细胞计数可预测鳞状细胞癌的严重程度。对于小细胞肺癌患者,AISI、SIRI、SII、d-NLR、EMR、ENR、MLR、白细胞计数、淋巴细胞计数、中性粒细胞计数、血小板计数、慢性阻塞性肺疾病(COPD)、吸烟和男性性别是病情严重程度的预测指标。了解不同组织学类型肺癌炎症反应的复杂性和变异性,可为制定个性化治疗方案提供依据,并针对特定异常细胞系进行治疗,从而改善这种高致死性疾病的治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a745/12072615/c53f2fbef3df/jcm-14-03038-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a745/12072615/65ba56b8142b/jcm-14-03038-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a745/12072615/ad52410afad5/jcm-14-03038-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a745/12072615/ca243643a8f8/jcm-14-03038-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a745/12072615/7bedc8538ee5/jcm-14-03038-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a745/12072615/9b1a0786623a/jcm-14-03038-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a745/12072615/c53f2fbef3df/jcm-14-03038-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a745/12072615/65ba56b8142b/jcm-14-03038-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a745/12072615/ad52410afad5/jcm-14-03038-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a745/12072615/ca243643a8f8/jcm-14-03038-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a745/12072615/7bedc8538ee5/jcm-14-03038-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a745/12072615/9b1a0786623a/jcm-14-03038-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a745/12072615/c53f2fbef3df/jcm-14-03038-g006.jpg

相似文献

1
The Impact of the Histologic Types of Lung Cancer on CBC-Derived Inflammatory Markers-Current Knowledge and Future Perspectives.肺癌组织学类型对基于全血细胞计数得出的炎症标志物的影响——当前认知与未来展望
J Clin Med. 2025 Apr 28;14(9):3038. doi: 10.3390/jcm14093038.
2
[The relationship between the comprehensive blood inflammation indexes and stage I pneumoconiosis and its combined lung infections].[全血炎症指标与一期尘肺及其合并肺部感染的关系]
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2024 May 20;42(5):350-355. doi: 10.3760/cma.j.cn121094-20231010-00081.
3
Blood-Count-Derived Inflammatory Markers as Predictors of Response to Biologics and Small-Molecule Inhibitors in Psoriasis: A Multicenter Study.血细胞计数衍生的炎症标志物作为银屑病对生物制剂和小分子抑制剂反应的预测指标:一项多中心研究
J Clin Med. 2024 Jul 9;13(14):3992. doi: 10.3390/jcm13143992.
4
Associations of novel complete blood count-derived inflammatory markers with psoriasis: a systematic review and meta-analysis.新型全血细胞衍生炎症标志物与银屑病的相关性:系统评价和荟萃分析。
Arch Dermatol Res. 2024 May 24;316(6):228. doi: 10.1007/s00403-024-02994-2.
5
Complete blood count derived inflammation indexes predict outcome in COVID-19 patients: a study in Indonesia.全血细胞计数得出的炎症指标可预测新冠病毒肺炎患者的预后:印度尼西亚的一项研究
J Infect Dev Ctries. 2023 Mar 31;17(3):319-326. doi: 10.3855/jidc.16527.
6
Systemic Inflammatory Biomarkers and Chest CT Findings as Predictors of Acute Limb Ischemia Risk, Intensive Care Unit Admission, and Mortality in COVID-19 Patients.全身炎症生物标志物和胸部CT表现作为COVID-19患者急性肢体缺血风险、重症监护病房入院率和死亡率的预测指标
Diagnostics (Basel). 2022 Sep 30;12(10):2379. doi: 10.3390/diagnostics12102379.
7
Blood Count-Derived Inflammatory Markers Correlate with Lengthier Hospital Stay and Are Predictors of Pneumothorax Risk in Thoracic Trauma Patients.血常规衍生的炎症标志物与住院时间延长相关,是胸外伤患者气胸风险的预测指标。
Diagnostics (Basel). 2023 Mar 2;13(5):954. doi: 10.3390/diagnostics13050954.
8
Association between complete blood count-derived inflammatory markers and the risk of frailty and mortality in middle-aged and older adults.全血细胞计数衍生的炎症标志物与中年及老年人虚弱和死亡风险的关系。
Front Public Health. 2024 Jul 31;12:1427546. doi: 10.3389/fpubh.2024.1427546. eCollection 2024.
9
The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients.入院时的全身炎症指数可预测 COVID-19 患者的住院死亡率。
Molecules. 2020 Dec 4;25(23):5725. doi: 10.3390/molecules25235725.
10
Are IL-17 inhibitors superior to IL-23 inhibitors in reducing systemic inflammation in moderate-to-severe plaque psoriasis? A retrospective cohort study.在减轻中度至重度斑块状银屑病的全身炎症方面,白细胞介素-17抑制剂是否优于白细胞介素-23抑制剂?一项回顾性队列研究。
Arch Dermatol Res. 2025 Jan 13;317(1):232. doi: 10.1007/s00403-024-03768-6.

本文引用的文献

1
Association of Obesity and Skeletal Muscle with Postoperative Survival in Non-Small Cell Lung Cancer.肥胖与骨骼肌和非小细胞肺癌术后生存率的关联
Radiology. 2025 Jan;314(1):e241507. doi: 10.1148/radiol.241507.
2
Lung cancer and obesity: A contentious relationship (Review).肺癌与肥胖:存在争议的关系(综述)。
Oncol Rep. 2024 Nov;52(5). doi: 10.3892/or.2024.8817. Epub 2024 Nov 4.
3
Circulating RKIP and pRKIP in Early-Stage Lung Cancer: Results from a Pilot Study.早期肺癌中循环RKIP和磷酸化RKIP的水平:一项初步研究的结果
J Clin Med. 2024 Sep 29;13(19):5830. doi: 10.3390/jcm13195830.
4
Mechanisms by which obesity regulates inflammation and anti-tumor immunity in cancer.肥胖调节癌症炎症和抗肿瘤免疫的机制。
Biochem Biophys Res Commun. 2024 Nov 12;733:150437. doi: 10.1016/j.bbrc.2024.150437. Epub 2024 Jul 23.
5
How General and Inflammatory Status Impacts on the Prognosis of Patients Affected by Lung Cancer: State of the Art.一般状况和炎症状态如何影响肺癌患者的预后:现状
Biomedicines. 2024 Jul 12;12(7):1554. doi: 10.3390/biomedicines12071554.
6
Serum albumin and derived neutrophil-to-lymphocyte ratio are potential predictive biomarkers for immune checkpoint inhibitors in small cell lung cancer.血清白蛋白和衍生的中性粒细胞与淋巴细胞比值是小细胞肺癌免疫检查点抑制剂的潜在预测生物标志物。
Front Immunol. 2024 Jun 7;15:1327449. doi: 10.3389/fimmu.2024.1327449. eCollection 2024.
7
Associations of CBC-Derived inflammatory indicators with sarcopenia and mortality in adults: evidence from Nhanes 1999 ∼ 2006.基于 CBC 检测的炎症指标与成年人肌肉减少症和死亡率的相关性:来自 Nhanes 1999-2006 的证据。
BMC Geriatr. 2024 May 16;24(1):432. doi: 10.1186/s12877-024-05012-2.
8
Impact of Blood-Count-Derived Inflammatory Markers in Psoriatic Disease Progression.血常规衍生的炎症标志物在银屑病疾病进展中的影响
Life (Basel). 2024 Jan 12;14(1):114. doi: 10.3390/life14010114.
9
A Bibliometric Analysis of Comorbidity of COPD and Lung Cancer: Research Status and Future Directions.基于文献计量学的 COPD 与肺癌合并症分析:研究现状与未来方向。
Int J Chron Obstruct Pulmon Dis. 2023 Dec 22;18:3049-3065. doi: 10.2147/COPD.S425735. eCollection 2023.
10
Potential biomarkers for predicting immune response and outcomes in lung cancer patients undergoing thermal ablation.预测肺癌患者接受热消融治疗后免疫反应和结局的潜在生物标志物。
Front Immunol. 2023 Nov 1;14:1268331. doi: 10.3389/fimmu.2023.1268331. eCollection 2023.